3rd Quarter - Amendment

BROWN RUDNICK LLP for HOSPIRA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to prescription drug shortages: --P.L. 111-148: Patient Protection and Affordable Health Care Act provisions relating to biosimilar products.; --H.R. 1919: Safeguarding America's Pharmaceuticals Act of 2013; --H.R. 3204: The Drug Quality and Safety Act; --S. 957: The Drug Supply Chain Security Act; --S. 232: Medical Device Access and Innovation Protection Act

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN New Secr for Congr & Intgv Affairs, Dept. Labor 01-02
LISA LAYMAN SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 1919 (113th), H.R. 3204 (113th), S. 232 (113th), S. 957 (113th)

Pharmacy PHA

-- Issues relating to generic drug labeling -- S. 959: The Pharmaceutical Quality, Security and Accountability Act -- H.R. 3204: The Compounding Clarity Act

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN New —
HENRY W MENN —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 3204 (113th), S. 959 (113th)

Budget/Appropriations BUD

-- S. 1413: FDA User Fee Protection Act -- H.R. 2725: "FDA Safety Over Sequestration Act of 2013

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN New —
HENRY W MENN —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1413 (113th), H.R. 2725 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.